VOLUME
65 2004 NUMBER 1
Issue to be mailed the week of February 5, 2004
CME Pretest 3
CME Posttest 140
Editorial
4 Our Reviewers. Alan J. Gelenberg
[PDF]
Brainstorms
8 Symptoms and Circuits, Part 3: Schizophrenia. Stephen M.
Stahl
[PDF]
Original Articles
10 Glycogen Synthase Kinase-3: A Target for Novel Bipolar
Disorder Treatments. Todd D. Gould, Carlos A. Zarate, and
Husseini K. Manji
[Abstract]
[PDF]
22 Impact of Age at Onset and Duration of Illness on the
Expression of Comorbidities in Obsessive-Compulsive Disorder. [CME] Juliana B. Diniz, Maria C.
Rosario-Campos, Roseli G. Shavitt, Mariana Curi, Ana G. Hounie,
Sergio A. Brotto, and Euripedes C. Miguel
[Abstract]
[PDF]
28 Mental Health Service Utilization by Borderline Personality
Disorder Patients and Axis II Comparison Subjects Followed
Prospectively for 6 Years. Mary C. Zanarini, Frances R.
Frankenburg, John Hennen, and Kenneth R. Silk
[Abstract]
[PDF]
37 A Double-Blind Switch Study of Paroxetine and Venlafaxine
in Obsessive-Compulsive Disorder. Damiaan Denys, Harold J. G.
M. van Megen, Nic van der Wee, and Herman G. M. Westenberg
[Abstract]
[PDF]
44 Escitalopram Continuation Treatment Prevents Relapse of
Depressive Episodes. Mark Hyman Rapaport, Anjana Bose, and
Hongjie Zheng
[Abstract]
[PDF]
50 Zonisamide in the Treatment of Binge-Eating Disorder: An
Open-Label, Prospective Trial. Susan L. McElroy, Renu Kotwal,
James I. Hudson, Erik B. Nelson, and Paul E. Keck, Jr.
[Abstract]
[PDF]
57 Prolactin Levels in Schizophrenia and Schizoaffective
Disorder Patients Treated With Clozapine, Olanzapine,
Risperidone, or Haloperidol. Jan Volavka, Pal Czobor, Thomas
B. Cooper, Brian Sheitman, Jean-Pierre Lindenmayer, Leslie
Citrome, Joseph P. McEvoy, and Jeffrey A. Lieberman
[Abstract]
[PDF]
62 A Placebo-Controlled Trial of Bupropion SR as an Antidote
for Selective Serotonin Reuptake Inhibitor-Induced Sexual
Dysfunction. Anita H. Clayton, Julia K. Warnock, Susan G.
Kornstein, Relana Pinkerton, Adrienne Sheldon-Keller, and
Elizabeth L. McGarvey
[Abstract]
[PDF]
68 Single-Dose Intravenous Valproate in Acute Mania.
Katrina Phrolov, Julia Applebaum, Joseph Levine, Hanoch
Miodovnick, and R. H. Belmaker
[Abstract]
[PDF]
71 In the Puerperium, Primiparae Exhibit Higher Levels of
Anxiety and Serum Peptidase Activity and Greater Immune Responses
Than Multiparae. Michael Maes, Eugene Bosmans, and Willem
Ombelet
[Abstract]
[PDF]
77 Lifetime History of Sexual Abuse, Clinical Presentation,
and Outcome in a Clinical Trial for Adolescent Depression.
Rémy P. Barbe, Jeffrey A. Bridge, Boris Birmaher, David J.
Kolko, and David A. Brent
[Abstract]
[PDF]
84 Gabapentin Reduces Cocaine Use Among Addicts From a
Community Clinic Sample. Wilfrid Noel Raby and Siobhan
Coomaraswamy
[Abstract]
[PDF]
87 One-Year Follow-Up After Successful ECT: A Naturalistic
Study in Depressed Inpatients. Tom K. Birkenhäger, Jan-Willem
Renes, and Esther M. Pluijms
[Abstract]
[PDF]
92 Branched Chain Amino Acid Treatment of Tardive Dyskinesia
in Children and Adolescents. Mary Ann Richardson, Arthur M.
Small, Laura L. Read, Helen M. Chao, and James D. Clelland
[Abstract]
[PDF]
97 An Open-Label Trial of Sildenafil Addition in
Risperidone-Treated Male Schizophrenia Patients With Erectile
Dysfunction. Alex Aviv, Assaf Shelef, and Abraham Weizman
[Abstract]
[PDF]
104 Olanzapine Versus Placebo in the Treatment of Borderline
Personality Disorder. Michael P. Bogenschutz and H. George
Nurnberg
[Abstract]
[PDF]
110 The Effect of a Switch to Ziprasidone in an Adult
Population With Autistic Disorder: Chart Review of Naturalistic,
Open-Label Treatment. Seth A. Cohen, Brian J. Fitzgerald,
Shirin R. F. Khan, and Arif Khan
[Abstract]
[PDF]
114 A 3-Month, Randomized, Placebo-Controlled, Neuroleptic
Discontinuation Study in 100 People With Dementia: The
Neuropsychiatric Inventory Median Cutoff Is a Predictor of
Clinical Outcome. Clive G. Ballard, Alan Thomas, Jane Fossey,
Lesley Lee, Robin Jacoby, Marisa M. Lana, Carol Bannister, Rupert
McShane, Alan Swann, Ed Juszczak, and John T. O'Brien
[Abstract]
[PDF]
Academic Highlights
120 Guidelines for the Use of Long-Acting Injectable Atypical
Antipsychotics. [CME]
[Abstract]
[PDF]
Letters To the Editor
132 Hypomanic Episodes After Receiving Ziprasidone: An
Unintended "On-Off-On" Course of Treatment. Peter
Brieger
[PDF]
132 Worsened Agitation With Aripiprazole: Adverse Effect of
Dopamine Partial Agonism? John R. DeQuardo
[PDF]
133 Possible Role of Divalproex Sodium in Sedation Induced by
Antipsychotic Medications. Timothy R. Berigan
[PDF]
134 Valproate for Hostility in Schizophrenia Patients.
Kimberly H. Littrell, Richard G. Petty, Nicole M. Hilligoss,
Carol D. Kirshner, and Craig G. Johnson
[PDF]
134 Use of Propofol for Alcohol Withdrawal Delirium: A Case
Report. Junji Takeshita
[PDF]
135 Two Cases of Perospirone-Induced Mania in Schizophrenia.
Takayuki Yokoshima, Nori Takei, Kunihiko Tani, Masayoshi Kawai,
Yosho Minabe, and Norio Mori
[PDF]
Book Reviews 136
Worldview of Psychiatry 138
NOW@Psychiatrist.com 142
Information for authors
see www.psychiatrist.com/author.htm
for complete information